









Markets
/
Stocks
/
nasdaq-dmiiu
/

Drugs Made In America Acquisition II Units

DMIIU

10.020USD

0.000

Close 12/10, 16:00（ET）Quotes delayed by 15 min

657.06MMarket Cap

--P/E TTM



Drugs Made In America Acquisition II Units

10.020

0.000

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Drugs Made In America Acquisition II Units to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

---690.73K

Net income from continuing operations

---46.16K

Other non-cash items

--30.61K

Change in working capital

---565.82K

-Change in receivables

---566.27K

-Change in prepaid expenses

---10.42K

Cash from non-recurring investing activities

Cash from operating activities

---690.73K

Investing cash flow

Cash from non-current investing activities

Net cash flow from investing activities

---500.00M

Financing cash flow

Cash flow from continuous financing activities

--501.00M

Net cash flow from debt Issuance/repayment

---533.78K

Net cash flow from other financing activities

--501.54M

Net cash from non-recurrent financing activities

Net cash from financing activities

--501.00M

Net cash flow

Beginning cash balance

--4.39K

Current period cash flow changes

--310.69K

Ending cash balance

--315.09K

Free cash flow

---690.73K

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

